HOTGEN COVID-19 ANTIGEN HOME TEST AT-HOME USE RESULTS IN 15 MINS

Serial Number 97650014
Registration 7681112
700

Registration Progress

Application Filed
Oct 27, 2022
Under Examination
Apr 16, 2024
Approved for Publication
Jan 31, 2024
Published for Opposition
Feb 20, 2024
Registered
Feb 4, 2025

Trademark Image

HOTGEN COVID-19 ANTIGEN HOME TEST AT-HOME USE RESULTS IN 15 MINS

Basic Information

Serial Number
97650014
Registration Number
7681112
Filing Date
October 27, 2022
Registration Date
February 4, 2025
Published for Opposition
February 20, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 4, 2025
Registration
Registered
Classes
005

Rights Holder

Beijing Hotgen Biotech Co., Ltd.

16
Address
9th Building, No. 9 Tianfu Street
Beijing 102600
CN

Ownership History

Beijing Hotgen Biotech Co., Ltd.

Original Applicant
16
Beijing CN

Beijing Hotgen Biotech Co., Ltd.

Owner at Publication
16
Beijing CN

Beijing Hotgen Biotech Co., Ltd.

Original Registrant
16
Beijing CN

Legal Representation

Attorney
Gregory P Brummett

USPTO Deadlines

Next Deadline
2012 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-04)
Due Date
February 04, 2031
Grace Period Ends
August 04, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

31 events
Date Code Type Description Documents
Feb 4, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 4, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 10, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 10, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 1, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 31, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 16, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 16, 2024 IUAF S USE AMENDMENT FILED Loading...
Apr 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 20, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 31, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 16, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 10, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 10, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 10, 2024 ALIE A ASSIGNED TO LIE Loading...
Aug 15, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Aug 15, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 15, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Aug 15, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Aug 9, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 9, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 9, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 9, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 9, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 9, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 2, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 11, 2022 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 10, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 31, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of COVID-19; diagnostic preparations for medical and veterinary use for diagnosing COVID-19; sanitary preparations for medical purposes for preventing the spread of COVID-19; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in testing COVID-19 antigens
First Use Anywhere: Jan 3, 2023
First Use in Commerce: Jan 3, 2023

Additional Information

Design Mark
The mark consists of several curved gray lines across the upper portion of a white rectangular background with a curved tan and green shaded bottom portion. Superimposed onto the white rectangular background is the term "HOTGEN" in the upper left where "HOT" is in red and "GEN" is in green. On the top of the "N" in "GEN" sits an orange and white butterfly. Sitting below is the wording "COVID-19 ANTIGEN HOME TEST" in green underlined with a green horizontal line, both stacked above the wording "AT-HOME USE RESULTS IN 15 MINS" in green. To the right of the wording "AT-HOME USE" as well as "RESULTS IN 15 MINS" are incomplete outlines of a circle with a tan check mark within each one. To the right of all of the wording is a profile of a woman's head with beige skin, grey hair, pink lips, and other facial features in or are outlined in black. The woman is wearing a white shirt and has a grey nasal swab being applied to her left nostril and a red graphic indicating rotation of the nasal swab.
Color Claim
The color(s) green, tan, white, red, orange, black, grey, beige, and pink is/are claimed as a feature of the mark.
Pseudo Mark
HOT GEN COVID NINETEEN ANTIGEN HOME TEST AT HOME USE RESULTS IN FIFTEEN MINUTES; HOT GEN COVID ONE NINE ANTIGEN HOME TEST AT HOME USE RESULTS IN ONE FIVE MINUTES

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"COVID-19 ANTIGEN HOME TEST AT-HOME USE RESULTS IN 15 MINS"